İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

DERYA OSMANİYE

DOÇENT

ANADOLU ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 112
  • Proje 0
  • Kitap 2
  • Bildiri 48
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 33 Q2 37 Q3 14 Q4 6
WoS (JCR) Q1 16 Q2 45 Q3 17 Q4 12
TR Index 12 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 22
Ort. yüzdelik 69.2%
Üst %1 payı 0.0%
Üst %10 payı 25.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 112 yayın

Scopus (SJR)
Q1 33 Q2 37 Q3 14 Q4 6
WoS (JCR)
Q1 16 Q2 45 Q3 17 Q4 12
TR Index
12 makale

Makale listesi

  1. 2025 Correction: Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors RSC Advances DOI 10.1039/D5RA90135A YÖKSİS SJR Q1 JCR Q2
  2. 2025 Exploring SAR and Antifungal Activity of Pyrazole‐Thiazole‐Hydrazone Compounds Through Synthesis and Docking Studies Chemistry & Biodiversity DOI 10.1002/cbdv.202501313 YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.7%
  3. 2025 Synthesis, Characterization, and In Vitro and In Silico Studies of New Triazole Derivatives as Aromatase Inhibitors Medicinal Chemistry DOI 10.2174/0115734064316112240722092935 YÖKSİS SJR Q3 JCR Q3 OpenAlex 68.2%
  4. 2025 Synthesis of new piperazine‐oxadiazole derivatives and investigation of their anticancer activities Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140298 YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.7%
  5. 2025 Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment Archiv der Pharmazie DOI 10.1002/ardp.70122 YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.5%
  6. 2025 Multi-Target Quinoxaline Derivatives for Alzheimer’s Disease: Inhibitory Activities Against AChE and BACE-1 Enzymes Polycyclic Aromatic Compounds DOI 10.1080/10406638.2024.2442581 YÖKSİS SJR Q3 JCR Q2 OpenAlex 21.6%
  7. 2025 Synthesis and biological evaluation of novel hydrazone derivatives for the treatment of Alzheimers disease RSC Advances DOI 10.1039/D5RA05755H YÖKSİS SJR Q1 JCR Q2 OpenAlex 84.0%
  8. 2025 Design, synthesis, and antiproliferative activity evaluation of novel cyclic secondary amine containing dithiocarbamate derivatives as potent EGFR inhibitors Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.142036 YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.9%
  9. 2025 Design and Synthesis of Thiadiazole Derivatives as Dual EGFR/COX-2 Inhibitors with Anticancer and Anti-inflammatory Activities ACS Omega DOI 10.1021/acsomega.5c09752 YÖKSİS SJR Q1 JCR Q2 OpenAlex 86.1%
  10. 2025 Discovery of Novel Thiazolohydrazone Derivatives as an Alternative Option in the Treatment of Zoonotic Toxocara canis : In Vitro and In Silico Evaluation Veterinary Medicine and Science DOI 10.1002/vms3.70144 YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.3%
  11. 2025 Targeting Cancer with New Morpholine-Benzimidazole-Oxadiazole Derivatives: Synthesis, Biological Evaluation, and Computational Insights ACS Omega DOI 10.1021/acsomega.5c03795 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 90.4%
  12. 2025 In vivo evaluation of the antinociceptive effects of novel methylsulfonyl group-containing compounds Zeitschrift für Naturforschung C DOI 10.1515/znc-2024-0210 YÖKSİS SJR Q3 JCR Q3 OpenAlex 2.7%
  13. 2025 Hipertansiyon Tedavisi İçin Yeni Ace İnhibitörlerinin Tasarımı, Sentezi, Moleküler Doking-Dinamik Çalışmaları Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi DOI 10.35193/bseufbd.1495751 YÖKSİS TR Index OpenAlex 11.0%
  14. 2024 Design, Synthesis, and Biological Effect Studies of Novel Benzofuran–Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors ACS Omega DOI 10.1021/acsomega.3c07703 YÖKSİS SJR Q1 JCR Q2 OpenAlex 56.1%
  15. 2024 Design, Synthesis, Investigation, and Biological Activity Assessments of (4-Substituted-Phenyl)-N-(3-morpholinopropyl)-3-phenylthiazol-2(3H)-imine Derivatives as Antifungal Agents ACS Omega DOI 10.1021/acsomega.3c07879 YÖKSİS SJR Q1 JCR Q2 OpenAlex 44.8%
  16. 2024 New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies ACS Omega DOI 10.1021/acsomega.3c10345 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.1%
  17. 2024 Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors Elsevier BV DOI 10.1016/j.molstruc.2023.136903 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 91.2%
  18. 2024 Investigation of anticancer effects of novel piperidine-oxadiazole and piperidine-triazole derivatives as VEGFR inhibitors and evaluation of their molecular docking-dynamic studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.139012 YÖKSİS SJR Q2 JCR Q2 OpenAlex 80.4%
  19. 2024 Synthesis, molecular dynamics simulation, and evaluation of biological activity of novel flurbiprofen and ibuprofen‐like compounds Journal of Molecular Recognition DOI 10.1002/jmr.3089 YÖKSİS SJR Q3 JCR Q2 OpenAlex 60.2%
  20. 2024 Design, synthesis, and investigation of biological activities of new triazole derivatives with antifungal effect Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.138277 YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.0%

Akademisyenlere dön